Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Foster City, California
- Most recent report
- 8-K, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 886744
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 69
News 8 of 229
- 8-K Quarterly results Aug 6, 2026
- 8-K Leadership change May 27, 2026
- 8-K Leadership change Mar 26, 2026
- 8-K Quarterly results Feb 25, 2026
- 8-K Current report on a material event Jan 12, 2026
- 8-K Significant contract Jan 6, 2026
- 8-K Current report on a material event Dec 16, 2025
- 8-K Quarterly results Nov 5, 2025
Prospectuses and Registrations 8 of 49
- S-8 Registration statement for an employee plan Aug 5, 2026
- S-3ASR Automatic shelf registration Mar 2, 2026
- S-8 Registration statement for an employee plan Aug 6, 2025
- S-8 Registration statement for an employee plan Jun 30, 2025
- S-8 Registration statement for an employee plan Jan 10, 2025
- 424B5 Prospectus supplement for an offering Mar 20, 2024
- 424B5 Prospectus supplement for an offering Nov 2, 2023
- S-8 Registration statement for an employee plan Aug 3, 2023
Proxies 8 of 41
- DEFA14A Extra proxy material Apr 7, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2026
- DEFA14A Extra proxy material Apr 8, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 8, 2025
- DEFA14A Extra proxy material Mar 27, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 27, 2024
- DEFA14A Extra proxy material Apr 14, 2023
- DEFA14A Extra proxy material Apr 12, 2023
Ownership 8 of 565
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 7, 2026
- 4 Insider reported a trade Jul 1, 2026
- 4 Insider reported a trade May 26, 2026
- 4 Insider reported a trade May 26, 2026
- 4 Insider reported a trade May 26, 2026
- 4 Insider reported a trade May 26, 2026
- 4 Insider reported a trade May 26, 2026
Other 8 of 48
- ARS Annual report sent to shareholders Apr 7, 2026
- ARS Annual report sent to shareholders Apr 8, 2025
- ARS Annual report sent to shareholders Mar 27, 2024
- ARS Annual report sent to shareholders Apr 20, 2023
- SEC STAFF LETTER Mar 5, 2021
- SEC STAFF LETTER Feb 4, 2021
- EFFECT Notice that a registration became effective Nov 6, 2020
- CORRESP Reply to SEC staff Nov 4, 2020
Everything here comes from Geron Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.